Medical cannabis company backed by Snoop Dogg launches on London Stock Exchange
CNBC that the money raised from the IPO will go towards developing four new drugs. “The key here is about getting cannabinoids into the hands of patients and the way you do that is through the drug development process,” Lucas said. “The medical cannabis, the problem with that is that physicians cannot prescribe it, so we want a drug product that we can get into the hands of physicians, into the hands of patients,” he added. Two of the company’s drug products will be heading into clinical trials following the IPO. According to Proactive Investors, OCT has a proprietary library of 9...